Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3

Category Primary study
JournalInvestigative Ophthalmology and Visual Science
Year 2021
This article has no abstract
Epistemonikos ID: e74e381b57f4ea4d01bf88732e1bdc1ae62f4ee6
First added on: Feb 13, 2025